Valuation: Edwards Lifesciences Corporation

Market Cap 52.59B 46B 42.42B 39.25B 74.5B 5,020B 75.75B 508B 199B 2,465B 197B 193B 8,538B P/E 2026 *
32.6x
P/E 2027 * 27.9x
Enterprise Value 49.11B 42.96B 39.61B 36.65B 69.57B 4,687B 70.73B 474B 186B 2,302B 184B 180B 7,973B EV / Sales 2026 *
7.28x
EV / Sales 2027 * 6.41x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day-0.09%
1 week-3.99%
Current month+1.02%
1 month+6.29%
3 months+17.36%
6 months+10.09%
Current year+7.20%
1 week 90.69
Extreme 90.69
96.29
1 month 83.17
Extreme 83.17
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
07-07Tax

Executive/Senior Manager

-377 0.0001%
06-30Fiscal year

Executive/Senior Manager

1,857 0.0003%
06-17Sell

Chief Executive Officer

-523 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.08%-3.99%+15.97%-0.28% 52.59B
-0.07%+1.59%+22.08%+1.74% 195B
-1.65%-6.34%-22.93%+19.14% 146B
-0.98%+0.04%-57.04%-15.33% 66.87B
+0.61%-1.09%-27.71%-30.42% 43.85B
+0.12%+2.54%+7.85%+13.15% 37.73B
+0.05%-0.30%+6.92%+42.73% 37.03B
-1.65%-6.08%-20.52%-5.30% 30.07B
-0.30%-0.49%-15.66%-20.01% 29.43B
-1.26%-1.78%+90.77%+3.77% 29.32B
Average -0.52%-1.48%-0.03%+0.92% 66.76B
Weighted average by Cap. -0.57%-1.64%-1.63%+3.29%

Financials

2026 *2027 *
Net sales 6.75B 5.9B 5.44B 5.04B 9.56B 644B 9.72B 65.19B 25.56B 316B 25.33B 24.78B 1,096B 7.41B 6.48B 5.98B 5.53B 10.5B 707B 10.67B 71.59B 28.06B 347B 27.82B 27.22B 1,203B
Net income 1.62B 1.42B 1.31B 1.21B 2.3B 155B 2.34B 15.69B 6.15B 76.14B 6.1B 5.97B 264B 1.89B 1.65B 1.53B 1.41B 2.68B 181B 2.72B 18.27B 7.16B 88.64B 7.1B 6.95B 307B
Net Debt -3.48B -3.05B -2.81B -2.6B -4.93B -332B -5.02B -33.64B -13.19B -163B -13.07B -12.79B -565B -5.07B -4.44B -4.09B -3.79B -7.19B -484B -7.31B -49.01B -19.21B -238B -19.04B -18.63B -824B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
10/07/26 US$91.36 +0.03% 979,007
09/07/26 US$91.33 -2.47% 5,578,677
08/07/26 US$93.64 -1.24% 3,673,430
07/07/26 US$94.82 -0.38% 4,445,101
06/07/26 US$95.18 +0.86% 3,958,057
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
91.33USD
Average target price
97.92USD
Spread / Average Target
+7.22%

Quarterly revenue - Rate of surprise